Carteolol hydrochloride
CAS No. 51781-21-6
Carteolol hydrochloride ( NSC 300906; OPC 1085 )
Catalog No. M14804 CAS No. 51781-21-6
A non-selective beta blocker used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 28 | In Stock |
|
25MG | 43 | In Stock |
|
50MG | 65 | In Stock |
|
100MG | 102 | In Stock |
|
200MG | 151 | In Stock |
|
500MG | 254 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCarteolol hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionA non-selective beta blocker used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
-
DescriptionA non-selective beta blocker used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.Other Indication Approved
-
SynonymsNSC 300906; OPC 1085
-
PathwayAngiogenesis
-
TargetAdrenergic Receptor
-
Recptorβ-adrenergicreceptor
-
Research AreaOther Indications
-
IndicationOther Disease
Chemical Information
-
CAS Number51781-21-6
-
Formula Weight328.83
-
Molecular FormulaC16H25ClN2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 13.33 mg/mL
-
SMILESCC(C)(C)NCC(COC1=CC=CC2=C1CCC(=O)N2)O.Cl
-
Chemical Name2(1H)-Quinolinone, 5-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-3,4-dihydro-,hydrochloride (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Silodosin
A highly potent, uroselective α1a-adrenoceptor antagonist with Ki of 36 pM; displays 583- and 56-fold lower potency against α1b and α1d respectors, respectively.
-
Levosalbutamol
A short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
-
TAK-259
A potent and selective human α1D adrenoceptor (α1D-AR) antagonist with Ki of 1.1 nM; displays 200-fold and 800-fold selectivity against α1A- and α1B-AR, respectively.